These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

265 related articles for article (PubMed ID: 27778157)

  • 1. Magnetic resonance imaging of the proximal upper extremity musculature in boys with Duchenne muscular dystrophy.
    Willcocks RJ; Triplett WT; Forbes SC; Arora H; Senesac CR; Lott DJ; Nicholson TR; Rooney WD; Walter GA; Vandenborne K
    J Neurol; 2017 Jan; 264(1):64-71. PubMed ID: 27778157
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Upper and Lower Extremities in Duchenne Muscular Dystrophy Evaluated with Quantitative MRI and Proton MR Spectroscopy in a Multicenter Cohort.
    Forbes SC; Arora H; Willcocks RJ; Triplett WT; Rooney WD; Barnard AM; Alabasi U; Wang DJ; Lott DJ; Senesac CR; Harrington AT; Finanger EL; Tennekoon GI; Brandsema J; Daniels MJ; Sweeney HL; Walter GA; Vandenborne K
    Radiology; 2020 Jun; 295(3):616-625. PubMed ID: 32286193
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Skeletal muscle magnetic resonance biomarkers correlate with function and sentinel events in Duchenne muscular dystrophy.
    Barnard AM; Willcocks RJ; Finanger EL; Daniels MJ; Triplett WT; Rooney WD; Lott DJ; Forbes SC; Wang DJ; Senesac CR; Harrington AT; Finkel RS; Russman BS; Byrne BJ; Tennekoon GI; Walter GA; Sweeney HL; Vandenborne K
    PLoS One; 2018; 13(3):e0194283. PubMed ID: 29554116
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Upper Limb Evaluation in Duchenne Muscular Dystrophy: Fat-Water Quantification by MRI, Muscle Force and Function Define Endpoints for Clinical Trials.
    Ricotti V; Evans MR; Sinclair CD; Butler JW; Ridout DA; Hogrel JY; Emira A; Morrow JM; Reilly MM; Hanna MG; Janiczek RL; Matthews PM; Yousry TA; Muntoni F; Thornton JS
    PLoS One; 2016; 11(9):e0162542. PubMed ID: 27649492
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clinical utilisation of multimodal quantitative magnetic resonance imaging in investigating muscular damage in Duchenne muscular dystrophy: a study on the association between gluteal muscle groups and motor function.
    Song Y; Xu HY; Xu K; Guo YK; Xie LJ; Peng F; Xu R; Fu H; Yuan WF; Zhou ZQ; Cheng BC; Fu C; Zhou H; Cai XT; Li XS
    Pediatr Radiol; 2023 Jul; 53(8):1648-1658. PubMed ID: 36892624
    [TBL] [Abstract][Full Text] [Related]  

  • 6. MR biomarkers predict clinical function in Duchenne muscular dystrophy.
    Barnard AM; Willcocks RJ; Triplett WT; Forbes SC; Daniels MJ; Chakraborty S; Lott DJ; Senesac CR; Finanger EL; Harrington AT; Tennekoon G; Arora H; Wang DJ; Sweeney HL; Rooney WD; Walter GA; Vandenborne K
    Neurology; 2020 Mar; 94(9):e897-e909. PubMed ID: 32024675
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Multicenter prospective longitudinal study of magnetic resonance biomarkers in a large duchenne muscular dystrophy cohort.
    Willcocks RJ; Rooney WD; Triplett WT; Forbes SC; Lott DJ; Senesac CR; Daniels MJ; Wang DJ; Harrington AT; Tennekoon GI; Russman BS; Finanger EL; Byrne BJ; Finkel RS; Walter GA; Sweeney HL; Vandenborne K
    Ann Neurol; 2016 Apr; 79(4):535-47. PubMed ID: 26891991
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Quantifying disease activity in fatty-infiltrated skeletal muscle by IDEAL-CPMG in Duchenne muscular dystrophy.
    Mankodi A; Bishop CA; Auh S; Newbould RD; Fischbeck KH; Janiczek RL
    Neuromuscul Disord; 2016 Oct; 26(10):650-658. PubMed ID: 27593185
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Longitudinal Evaluation of Muscle Composition Using Magnetic Resonance in 4 Boys With Duchenne Muscular Dystrophy: Case Series.
    Senesac CR; Lott DJ; Forbes SC; Mathur S; Arpan I; Senesac ES; Walter GA; Vandenborne K
    Phys Ther; 2015 Jul; 95(7):978-88. PubMed ID: 25592189
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Skeletal muscles of ambulant children with Duchenne muscular dystrophy: validation of multicenter study of evaluation with MR imaging and MR spectroscopy.
    Forbes SC; Walter GA; Rooney WD; Wang DJ; DeVos S; Pollaro J; Triplett W; Lott DJ; Willcocks RJ; Senesac C; Daniels MJ; Byrne BJ; Russman B; Finkel RS; Meyer JS; Sweeney HL; Vandenborne K
    Radiology; 2013 Oct; 269(1):198-207. PubMed ID: 23696684
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Lower Extremity Muscle Involvement in the Intermediate and Bethlem Myopathy Forms of COL6-Related Dystrophy and Duchenne Muscular Dystrophy: A Cross-Sectional Study.
    Batra A; Lott DJ; Willcocks R; Forbes SC; Triplett W; Dastgir J; Yun P; Reghan Foley A; Bönnemann CG; Vandenborne K; Walter GA
    J Neuromuscul Dis; 2020; 7(4):407-417. PubMed ID: 32538860
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Quantitative Skeletal Muscle MRI: Part 2, MR Spectroscopy and T2 Relaxation Time Mapping-Comparison Between Boys With Duchenne Muscular Dystrophy and Healthy Boys.
    Kim HK; Serai S; Lindquist D; Merrow AC; Horn PS; Kim DH; Wong BL
    AJR Am J Roentgenol; 2015 Aug; 205(2):W216-23. PubMed ID: 26204310
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Quantitative magnetic resonance imaging measures as biomarkers of disease progression in boys with Duchenne muscular dystrophy: a phase 2 trial of domagrozumab.
    Sherlock SP; Palmer J; Wagner KR; Abdel-Hamid HZ; Bertini E; Tian C; Mah JK; Kostera-Pruszczyk A; Muntoni F; Guglieri M; Brandsema JF; Mercuri E; Butterfield RJ; McDonald CM; Charnas L; Marraffino S
    J Neurol; 2022 Aug; 269(8):4421-4435. PubMed ID: 35396602
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clinical importance of changes in magnetic resonance biomarkers for Duchenne muscular dystrophy.
    Willcocks RJ; Barnard AM; Daniels MJ; Forbes SC; Triplett WT; Brandsema JF; Finanger EL; Rooney WD; Kim S; Wang DJ; Lott DJ; Senesac CR; Walter GA; Sweeney HL; Vandenborne K
    Ann Clin Transl Neurol; 2024 Jan; 11(1):67-78. PubMed ID: 37932907
    [TBL] [Abstract][Full Text] [Related]  

  • 15. T2 Mapping and Fat Quantification of Thigh Muscles in Children with Duchenne Muscular Dystrophy.
    Yin L; Xie ZY; Xu HY; Zheng SS; Wang ZX; Xiao JX; Yuan Y
    Curr Med Sci; 2019 Feb; 39(1):138-145. PubMed ID: 30868504
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Upper limb disease evolution in exon 53 skipping eligible patients with Duchenne muscular dystrophy.
    Lilien C; Reyngoudt H; Seferian AM; Gidaro T; Annoussamy M; Chê V; Decostre V; Ledoux I; Le Louër J; Guemas E; Muntoni F; Hogrel JY; Carlier PG; Servais L;
    Ann Clin Transl Neurol; 2021 Oct; 8(10):1938-1950. PubMed ID: 34453498
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Elevated phosphodiester and T
    Hooijmans MT; Niks EH; Burakiewicz J; Verschuuren JJ; Webb AG; Kan HE
    NMR Biomed; 2017 Jan; 30(1):. PubMed ID: 27859827
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Longitudinal study of multi-parameter quantitative magnetic resonance imaging in Duchenne muscular dystrophy: hyperresponsiveness of gluteus maximus and detection of subclinical disease progression in functionally stable patients.
    Peng F; Xu H; Song Y; Xu K; Li S; Cai X; Guo Y; Gong L
    J Neurol; 2023 Mar; 270(3):1439-1451. PubMed ID: 36385201
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Modeling disease trajectory in Duchenne muscular dystrophy.
    Rooney WD; Berlow YA; Triplett WT; Forbes SC; Willcocks RJ; Wang DJ; Arpan I; Arora H; Senesac C; Lott DJ; Tennekoon G; Finkel R; Russman BS; Finanger EL; Chakraborty S; O'Brien E; Moloney B; Barnard A; Sweeney HL; Daniels MJ; Walter GA; Vandenborne K
    Neurology; 2020 Apr; 94(15):e1622-e1633. PubMed ID: 32184340
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Muscle-MRI and Functional Levels for the Evaluation of Upper Limbs in Duchenne Muscular Dystrophy: A Critical Review of the Literature.
    Cristiano L; Brogna C; Tasca G; Verdolotti T; Pane M; Mercuri E
    Medicina (Kaunas); 2022 Mar; 58(3):. PubMed ID: 35334617
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.